by David Eyre | Jul 8, 2024 | EPO
These provisions for “second medical use” also rely on the claims for use in a method of treatment being interpreted to include the physiological or technical effect of the treatment as being a functional feature of the claim. However, the interpretation...
by Juliette Boynton | Jul 2, 2024 | US & International
However, in a significant development we now report, means-plus-function language for a claim to an antibody complied with both of the USPTO requirements for written description and for the claim not to be indefinite. Where functional language alone is used in US...
by David Eyre | Jun 26, 2024 | Designs & Copyright, US & International
Registered Design Rights be they UK Registered Design Rights, European Registered Design Rights, US Design Patents or Registered Design Rights granted in other jurisdictions are highly useful Intellectual Property Rights that have been increasing in commercial...
by Vicky Colley | Jun 13, 2024 | News
A full list of all recommended law firms can be found here Research was compiled by the Financial Times and Statista to bring together a list of recommended firms. These firms have been categorized by their speciality, with Schlich being among the top Biotechnology,...
by Sean Hutchinson | Jun 12, 2024 | EPO
Background In our article of January 2024, we reported that the opponent in the case underpinning the “plausibility” referral (G 2/21) had filed a petition for review of the referring board’s decision (T 116/18) by the Enlarged Board of Appeal. That petition is...
Recent Comments